Update on Diagnosis and Treatment within the Four Clinical Phases of Chronic Hepatitis B Infection Brian J. McMahonBrenna C. SimonsStephen E. Livingston Hepatitis B: Epidemiology, Natural History, Treatment, and Transplantation (Thomas Berg and Steven-Huy Han, Section Editors) 19 August 2011 Pages: 229 - 234
Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety Yuk-Fai LamMan-Fung YuenChing-Lung Lai Hepatitis B: Epidemiology, Natural History, Treatment, and Transplantation (Thomas Berg and Steven-Huy Han, Section Editors) Open access 09 August 2011 Pages: 235 - 243
Hepatitis B virus Resistance to Antivirals : Diagnosis and Management Olivier LadaTarik AsselahPatrick Marcellin Hepatitis B: Epidemiology, Natural History, Treatment, and Transplantation (Thomas Berg and Steven-Huy Han, Section Editors) 15 October 2011 Pages: 244 - 254
Hepatitis B and Liver Transplantation: Update in Management before and after Transplantation Matthew S. ChangRobert S. Brown Jr. Hepatitis B: Epidemiology, Natural History, Treatment, and Transplantation (Thomas Berg and Steven-Huy Han, Section Editors) 09 August 2011 Pages: 255 - 261
Management of Hepatitis B Virus Coinfection: HIV, Hepatitis C Virus, Hepatitis D Virus Kalyan Ram BhamidimarriJames ParkDouglas Dieterich Hepatitis B: Epidemiology, Natural History, Treatment, and Transplantation (Thomas Berg and Steven-Huy Han, Section Editors) 04 November 2011 Pages: 262 - 268
Management of Chronic Hepatitis B in Special Populations: Immunosuppressed Patients and Chronic Kidney Disease Fabrizio FabriziVivek DixitPaul Martin Hepatitis B: Epidemiology, Natural History, Treatment, and Transplantation (Thomas Berg and Steven-Huy Han, Section Editors) 29 September 2011 Pages: 269 - 276
Epigenetic Regulation of Hepatitis B Virus Infection Douglas MogulMichael TorbensonKathleen B. Schwarz Hepatitis B: Epidemiology, Natural History, Treatment, and Transplantation (Thomas Berg and Steven-Huy Han, Section Editors) 10 September 2011 Pages: 277 - 284
Interferon for Hepatitis B: Which Populations Benefit the Most Michael ChangSammy Saab Special Populations (Scott Cotler and Paul Kwo, Section Editors) 19 August 2011 Pages: 285 - 291
Goals of Antiviral Therapy for Hepatitis B: HBeAg Seroconversion, HBsAg Seroconversion, Histologic Improvement, and Possible Impact on Risk of Hepatocellular Carcinoma Petros C. BeniasAlbert D. Min Special Populations (Scott Cotler and Paul Kwo, Section Editors) 08 September 2011 Pages: 292 - 296